Home    Contact us    Sitemap
About AsCNP
Invitation
Meeting Information
Scientific Program
Call for Abstracts
Fellowship Award
Registration
Accommodation
Contribution & Sponsors List
  Platinum
 
  Gold
 
  Hosted by KCNP
 
 
Plenary Lecture
Young Hoon Kim
Department of Psychiatry, Inje University, Korea

Professor Young-Hoon Kim is Professor of Psychiatry at School of Medicine and former Director of Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. He has been a major opinion leader in the field of neurobiology and psychopharmacology in Korea and the President of Korean College of Neuropsychopharmacology (2005~2008). He graduated from Seoul National University in 1978 and received Ph.D. in Neurochemistry in 1992 from Inje University in Bu1san. He had research experiences in neuroscience at Kyoto Prefectural University, Japan (1990) and Pohang University of Science and Technology, Korea (1996). His current major research interests are in the mechanisms of neuroprotective action of atypical antipsychotic drugs against toxic models such as serum deprivation and MPP+ toxicity and  the  role of AKT-GSK3 signaling pathway in the action of atypical antipsychotic drugs. Another research interest in clinical field is to investigate the effects of cholinergic and glutamatergic drugs for the improvement in cognition of patients with schizophrenia.

 
Hans-Jürgen Möller
Department of Psychiatry,
Ludwig-Maimilian University,
Germany
Study of medicine at the Universities of Göttingen and Hamburg, Germany (1966-1971)
MD degree. Specialisation in psychiatry and scientific postgraduate training at the Max-Planck-Institute of Psychiatry in Munich (1972)
Senior psychiatrist at the Psychiatric Department of the Technical University in Munich (1979) Postdoctoral thesis in psychiatry (Habilitation) (1980)
Professor of Psychiatry (C3) at the Psychiatric Department of the Technical University Munich (1981-1988)
Full Professor of Psychiatry (C4) and Chairman of the Psychiatric Department at the University Bonn (1988-1994) to present Full Professor of Psychiatry (C4) and Chairman of the Psychiatric Department at the Ludwig-Maximilians-University Munich (1994)
Professor Möller is author or co-author of more than 1100 publications, such as original papers, reviews and other articles published in German and international journals.
Professor Möller is a Main editor of European Archives of Psychiatry and Clinical Neuroscience. Also, member of the editorial board of several national and international psychiatric journals, such as The World Journal of Biological Psychiatry after chief editorship from 2000 to 2009.
Main reaserch fields are Methodology of clinical research in psychiatry, biological psychiatry of schizophrenia and depression, clinical psychopharmacology and psychogeriatrics.
Special Lecture
John H. Krystal
Department of Psychiatry, Yale University School of Medicine, USA
Dr. Krystal is the Robert L. McNeil, Jr., Professor of Translational Research and Chair of the Department of Psychiatry of the Yale University School of Medicine and Chief of Psychiatry at Yale-New Haven Hospital. He is a graduate of the University of Chicago, Yale University School of Medicine, and the Yale Department of Psychiatry Residency Training Program. He has published over 350 papers and chapters on the neurobiology and treatment of alcoholism, schizophrenia, post-traumatic stress disorder, and depression. His research program unites psychopharmacology, neuroimaging, and molecular genetics. His work on brain glutamate systems contributed to the identification of novel treatment mechanisms for alcoholism, depression, and schizophrenia that are now in development. He is the Director of the NIAAA Center for the Translational Neuroscience of Alcoholism, VA Alcohol Research Center, and Clinical Neuroscience Division of the VA National Center for PTSD. Dr. Krystal received the Joel Elkes Award of the American College of Neuropsychopharmacology (ACNP), the APIRE/Kempf Fund Award of the American Psychiatric Association, the Anna-Monika Foundation Prize, the NIAAA Jack Mendelson Award, and other awards. He is also a member of the Institute of Medicine of the U.S. National Academies of Sciences. He was Chairman of the NIMH Board of Scientific Counselors (2004-2007) and he currently serves on the NIAAA National Alcohol Advisory Council and the Department of Defense Psychological Health Advisory Board. He has served in leadership roles in several professional societies and he is currently president-elect of the American College of Neuropsychopharmacology. Since 2006, he has edited one of the leading journals in psychiatry and neuroscience, Biological Psychiatry (IF=8.92).
 
Chang Yoon Kim
Department of Psychiatry, University of Ulsan, Korea

Chang Yoon Kim is a Professor of  Psychiatry , University of Ulsan College of Medicine, Asan Medical Center in Seoul.  His major areas of research interest include clinical psychopharmacology, psychopathology and genetic aspects of  schizophrenia and mood disorder. He had also been responsible for  the  development of computerized patient record system of  Asan Medical Center
As a psychiatrist, he also emphasizes  psychological treatment as well as pharmacotherapy.   He is running a ‘schizophrenia and mood disorder’ and  ‘obsessive compulsive disorder’ outpatient clinic and ‘social cognition enhancement program  for schizophrenia’.
He received his M.D (1984) and Ph.D (1991) at the Seoul National University, College of Medicine and medical training at the Seoul National University Hospital where he received psychiatric specialty in 1988.  He also had bench work training of molecular neurobiology at the ‘Laboratory of Molecular Neurobiology’ , Cornell University  in  White Plains, New York in 1994.   He has been working as a staff psychiatrist in Asan Medical Center since 1989 and has served as a Chief  in Psychiatry from 2000 to Aug. 2006.   He is one of the leading members of ‘Korean Society of Psychopharmacology’.

 
Anthony G. Phillips
Department of Psychiatry,
UBC Institute of Mental Health,
Canada
Dr. Anthony Phillips is a world-renowned expert in brain function and behaviour. He is the Scientific Director of the CIHR Institute of Neurosciences, Mental Health and Addiction, the Founding Director of the UBC Institute of Mental Health, a Professor in the Department of Psychiatry and a senior investigator with the University of British Columbia/Vancouver Coastal Health Brain Research Centre. He is a former Head of the UBC Department of Psychology.
Dr. Phillips earned his Bachelor of Arts, Master of Arts and PhD in Psychology from the University of Western Ontario, Canada. His research focuses on the neurobiology of motivation, drug addiction and mental illness, with a specific emphasis on clinical implications. He has published over 300 peer-reviewed papers, and is a Fellow of the Royal Society of Canada.
Dr. Phillips serves as a Councillor for the Society for Neuroscience and is Vice-President of the Collegium Internationale Neuro-Psychopharmacologicum (CINP). He has received numerous awards for his research including a Steacie Fellowship from NSERC; and most recently, the Heinz Lehmann Award from the Canadian College of Neuropsychopharmacology in March 2009. He maintains a very active and productive laboratory in systems neuroscience.
Dr. Phillips' research interests are broadly based within the field of Systems Neuroscience specifically related to brain mechanisms of motivation, emotion, learning and memory, as keys to understanding complex behavior and cognition.
 
Shigeto Yamawaki
Department of Psychiatry and Neurosciences,
Hiroshima University,
Japan
Dr. Shigeto Yamawaki is Professor and Chairman of Psychiatry and Neurosciences, Hiroshima University, Japan. He has served as Secretary (2004-2006) of the International College of Neuropsychopharmacology (CINP) and successfully organized the CINP Asia-Pacific regional meeting in Hiroshima, 2001. He has also served as President (2006-2008) of the International College of Geriatric Psychoneuropharmacology (ICGP), as a founding President (2008-2010) of the Asian College of Neuropsychopharmacology (AsCNP) and as a current President of the Japanese Society of Neuropsychopharmacology (JSNP).
Major focus of his research is on the neurobiology and clinical psychopharmacology of mood disorders. His recent interest includes the molecular basis of early adverse life events on vulnerability for major depression, and the neuroimaging study on mood regulation using a visual emotional task and a future reward prediction task. He published more than 300 papers in the high impact international journals including Nature Neuroscience, Biological Psychiatry etc.
Meet the Expert
Brian Dean
The Rebecca L. Cooper Research Laboratories, The Research Mental Health Research Research Institute, Australia
Brian Dean is currently a NHMRC Senior Research Fellow, leads the Rebecca Cooper Research Laboratory at the Mental Health Research Institute, is a Professor in the Department of Psychiatry at the University of Melbourne and is the Director of the Victorian Brain Bank Network. Since obtaining a doctoral degree from the University of Melbourne Professor Dean’s research has focused on understanding the pathophysiologies of serious psychiatric disorders such as schizophrenia, major depressive disorders and bipolar disorders and elaborating the mechanisms of action for drugs used to treat these disorders.
His work includes a number of significant findings that together suggest that cortical muscarinic, serotonin and cannabinoid receptors are important in the pathophysiology of schizophrenia and that these receptors may be targets for drugs to treat the symptoms of psychiatric disorders. Professor Dean uses a holistic approach to research using postmortem human CNS in conjunction with animal and cellular models to understand the mechanisms by which changes in the molecular cytoarchitecture of the human brain can induce the symptoms associated with psychiatric disorders. Professor Dean has published 180 papers many of which appear in the top 10 psychiatric journals. Professor Dean has significant roles in a number of significant scientific societies being currently Treasurer of the CINP, President of Biological Psychiatry Australia and President of the Melbourne Chapter of the Society of Neuroscience.
 
Joseph Zohar
Department of Psychiatry,
Chaim Sheba Medical Center,
Israel
Prof. Zohar is full professor of psychiatry at Tel Aviv University, and visiting professor of psychiatry at Maastricht University. He is director at the division of Psychiatry at Chaim Sheba Medical Center in Israel, and Chief Psychiatric Advisor to the Israeli Ministry of Defence. Prof. Zohar holds several International and National positions including President of ECNP (as of September 2010), Chair of ICOCS since 2005, Chair of the WPA section on OCD and Anxiety and Chair of the Israeli consortium on PTSD.
Prof. Zohar is board member for the International Master in Affective Neuroscience, and a board member for the Institution of Brain Medicine and the European Brain Council. He was founder and chair of the International Council on OCD (1992-2003), member of the Executive Committee of WFSBP (1997-2007), chair of the education committee of ECNP (1999-2007), and WFSBP (1998-2007), and a member of the education committee of CINP (2003-2007). He chaired the panel for OCD of the APA Task Force on Treatments of Psychiatric Disorders, and co-chaired the DSM-5-ICD working group on obsessive-compulsive behavior spectrum.
Prof. Zohar has been awarded, amongst others, the Fogarty International Research Fellowship Award (1984), the A.E. Bennet Award for Clinical Research (1986 and 2002), ECNP–Lilly Neuroscience Award for Clinical Research (1998), and the WFSBP Award for Excellence in Education (2001).
Prof. Zohar has authored more than 200 papers, has written or edited 14 books focusing on refractory depression, OCD and post-traumatic stress disorder, and was the founding associate editor of CNS Spectrums and of the World Journal of Biological Psychiatry.
 
Thematic Lecture
Xin Yu
Department of Clinical Psychiatry,
Peking University,
China
Residency in psychiatry, Institute of Mental Health, Beijing Medical University, (1988-1993 ) Psychiatrist, Institute of Mental Health, Beijing Medical University, (1993-1998)
Pfizer/Old Age Psychiatry Fellowship, St. George Hospital, Department of Psychiatry, Melbourne University, Australia (1996-1997)
Hubert Humphrey Fellowship, School of Public Health, Johns Hopkins University, USA (1998-1999) Head of Geriatric Psychiatric Department, Institute of Mental Health Peking University, Associate Professor of Psychiatry, Geriatric psychiatrist (1999-2001)
Assistant Director, Institute of Mental Health, Peking University (2000-2001 )
Executive Director, Peking University, Institute of Mental Health (2001-2004 )
Director, Clinical Professor of Psychiatry, Peking University Institute of Mental Health (2004-present)
Major research interests include dementia, late life depression and psychosis, substance abuse and first onset schizophrenia, neurocognitive function of HIV/AIDS President-elect of Chinese Society of Psychiatry (2009-2012);
Immediate past president of Chinese Psychiatrist Association (2008-2010);
Vice Chairman of Alzheimer’s Disease of China (2004-20012)
 
Shigenobu Kanba
Department of Neuropsychiatry University of Kyushu , Japan
Shigenobu Kanba was born in 1954 in Kyushu and brought up in Tokyo. After graduating Keio University School of Medicine, Tokyo in 1980, I moved to Mayo Clinic Rochester USA and stayed as research fellow and resident in Psychiatry from 1982 to 1987. In 1996, I became professor at Yamanashi University School of Medicine, and in 2003 moved to Kyushu University Graduate School of Medicine.
My research areas have been mood disorders, brain science (psychopharmacology, stress, psychoneuroimmunology) and behavioral genetics. I have published about 190 scientific papers and 14 book chapters.
I have served for World Federation of Societies of Biological Psychiatry as an Executive Committee member, Science Council of Japan as a Secretary of Psychiatric Committee, Japanese Ministry of Health, Labor and Welfare, as an Advisory member of Drug and Food Administration, and for International Society for Bipolar Disorder as a Council member.
I have served as an editor for Psychiatry and Clinical Neurosciences (Japan), Journal of Psychiatry and Neuroscience (Canada), Molecular Psychiatry (USA), Asian Journal of Psychiatry, Asia Pacific Journal of Psychiatry, Open Journal of Psychiatry, and Shanghai Archives of Psychiatry.
 
Yuan-Hwa Chou
Department of Psychiatry,
Taipei Veterans
General Hospital,
Taiwan
Dr. Yuan-Hwa Chou is an associate professor of psychiatry in National Yang Ming University at Taipei, Taiwan. He is currently responsible for the section of psychosomatic medicine at Taipei Veterans General Hospital. He had his PhD degree in Karolinka Institute in Stockholm specializing on the research of neuroreceptor image by using PET. He is funding member of AsCNP and actively participate in many international societies as well as in Asian region. Now, he is the vice president for AsCNP, vice president of East Asian Forum of Bipolar Disorder (EABD), general secretary in Asian Network of Bipolar Disorder (AND) and Educational committee of Schizophrenia International Research Society (SIRS). He was general secretary of Pacific Rim of Clinical Psychiatry (PRCP), Taiwanese Society of Psychiatry and funding member of Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology.
His major research interesting is on major psychiatric disorder such as schizophrenia and mood disorder. Currently, he is doing research on brain image and particular focusing on monoamine transporter and brain function in mood disorder. Besides, he is in charge of a National Clinical Trial of Treatment in Schizophrenia to find out the possible treatment guideline for Taiwan. He published more than 100 articles related to brain image and clinical trials. He received Paul-Jassen Award in schizophrenia research in Taiwan in 2010.
 

Evening Lecture

Sung Kil Min
Seoul Metropolitan Eunpyeong Hospital, Korea

Professor Min graduated from Yonsei University, Seoul, Korea with an M.D. degree in 1968, and he received a Ph.D from the same University in 1975. He has received training in psychiatry at Yonsei Medical Center and gone on study visits to Copenhagen University, Tuebingen University, and Illinois State University. In 1976, he became a professor of psychiatry at Yonsei University, and he served as chair of the Department of Psychiatry in 1994-2000, retiring as professor emeritus in 2009. Throughout the years he had held other positions of responsibility, such as president and chairman of the KCNP (1997-1999), president of the Korean Neuropsychiatric Association (1999-2001) and a lifetime member of the National Academy of Medicine of Korea. Since 2009, he has served as superintendent of Seoul Metropolitan Eunpyeong Hospital. He has had numerous articles and books published in the field of clinical psychopharmacology and in regard to hwa-byung, the culture-related anger syndrome of Korea, and he has edited a Korean textbook of psychiatry.

 

Luncheon Lecture

Min Soo Lee
Department of
Psychiatry,
Korea University,
Korea

Dr Min-Soo LEE is Professor and Director of the Department of Psychiatry at the Korea University, South Korea. He was educated and gained clinical and research experience in psychiatry at the College of Medicine of the Korea University, Psychiatric Department of Pohang Armed Forces General Hospital of Korean Navy, Neuropsychiatric Department of Capital Armed Forces General Hospital of Korean Navy, and Millhauser Laboratories at the Neuropsychiatric Department of New York University School of Medicine, USA. At present, Dr LEE serves as Concurrent Professor of Institute of Bio-Technology at Korea University, Director of Depression Center at Korea University Medical Center, Director of Pharmacogenomic Research Center for Psychotropic Drugs at Korea University, International Advisory Board of “Psychiatry and Clinical Neurosciences”, Director of Institute of Human Behavior and Genes at Korea University, and Associate Secretary-Treasurer of World Federation of Society of Biological Psychiatry (WFSBP). He is the elected president of Korean NeuroPsychiatricAssocationand Pacific Rim College of Psychiatrists. Dr LEE is interested in the genetic backgrounds of psychiatric disorders especially depression, and the genetic variations affecting on the responsiveness to psychotropic drugs. He has striven to develop biomarkers for predicting individual responses to antidepressant treatment. To do these, he has conducted pharmacogenetic and clinical studies on major psychiatric disorders in Korea and has published about250 research reports and reviews.

 

K-Special Lecture

Joseph Terwilliger Department of Genetics
and Development,
Columbia Genome Center, USA

My research is focused on development and application of computer software for statistical genetics applications including software for joint linkage and linkage disequilibrium analysis on arbitrarily large pedigrees (Pseudomarker) and software for assisting in the study design process for linkage and linkage disequilibrium analysis (Detectance) - in collaboration with researchers at the University of Helsinki; and software for simulating the evolution of phenogenetic relationships on a genome-wide scale under various models of mutation, selection, and population demographics (ForSim) in collaboration with researchers at Penn State University.
Additionally I am involved in study design and data analysis from numerous field studies in Kazakhstan, Finland, Korea, Venezuela, Mongolia, Russia, China, and Sweden among others. In furtherance of the latter applied aims, I organize and teach workshops on "Logical Reasoning in Human Genetics" in various places throughout the developing world, where the potential human genetic resources far surpass what we could ever hope to accomplish in cosmopolitan western societies like our own."

 

Ki Woong Kim
Department of
Neuropsychiatry, Bundang Seoul
National University,
Korea

Dr. Kim is an associate professor of the Department of Psychiatry, Seoul National University College of Medicine and the Department of Neuropsychiatry and Geriatric Medicine Center, Seoul National University Bundang Hospital. His major field of practice and research is cognitive disorders and late life depression. He is currently leading the Korean Longitudinal Study on Health and Aging (KLoSHA), a multidisciplinary longitudinal community-based cohort study, and the Korean Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD), a nationwide multicenter community-based cohort study.
He published more than 120 papers in peer-reviewed scientific journals including Biological Psychiatry, Neurology, and Stroke. He also wrote 9 books on dementia and geriatric psychiatry.
He is serving as vice president of the Korean Geriatric Psychoneuropharmacology (KCGP) and board member of the National Council for Dementia Management, the Korean Neuropsychiatric Association (KNPA), Korean Association of Geriatric Psychiatry and Korean Association of Dementia (KAD).